Related Experiment Videos
Phase IV study (postmarketing surveillance) of Tarivid (ofloxacin) in China
J T Li1, M Yoshida, K Nakatsuka
1Institute of Clinical Pharmacology, Beijing Medical University, China.
Drugs
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Efficacy analysis of maintenance therapy with levamisole compared to mycophenolate mofetil after rituximab treatment in children].
Zhonghua er ke za zhi = Chinese journal of pediatrics·2026
[The value and controversy of hepatopancreatoduodenectomy in the treatment of cholangiocarcinoma].
Zhonghua wai ke za zhi [Chinese journal of surgery]·2026
[Preliminary application of patient-derived tumor organoids in biliary tract cancers: analysis of 38 cases].
Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
[New perspective of diagnosis and treatment of hepatocellular carcinoma complicated with portal vein tumor thrombosis].
Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
[Treatment of refractory diffuse large B-cell lymphoma involving the central nervous system with polatuzumab vedotin-based regimen: a case report and literature review].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2024
[The variables affecting the time of B-cell reconstruction in children with steroid-sensitive nephrotic syndrome treated with rituximab].
Zhonghua er ke za zhi = Chinese journal of pediatrics·2024
Camizestrant: First Approval.
Drugs·2026
Autoantibodies neutralizing type I interferons in patients with life-threatening COVID-19 pneumonia: a meta-analysis from 2020-2026.
medRxiv : the preprint server for health sciences·2026
RelB proximity proteomics and CRISPR screening define chromatin regulators of noncanonical NF-κB control of HIV latency and reactivation.
bioRxiv : the preprint server for biology·2026
Tissue-resident memory B cells augment local anti-cancer immunity via IgA.
bioRxiv : the preprint server for biology·2026
First-in-Human, Randomized, Placebo-Controlled, Double-Blind Phase 1 Study to Assess in Healthy Adults the Safety and Immunogenicity of Intramuscularly Administered AAVLP-HPV Vaccine.
medRxiv : the preprint server for health sciences·2026